Analytic performance of immunoassays for drugs of abuse below established cutoff values

Clinical Chemistry

Volumn 50, Issue 4, 2004, Pages 717-722

  Luzzi, Veronica I ^a   Saunders, Al N ^b   Koenig, John W ^b   Turk, John ^a   Lo, Stanley F ^c   Garg, Uttam C ^d   Dietzen, Dennis J ^a,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZOYLECGONINE; CANNABINOID; ILLICIT DRUG; METHAMPHETAMINE; MORPHINE; OPIATE; PHENCYCLIDINE; TETRAHYDROCANNABINOL;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; DRUG SCREENING; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY;

COCAINE; DEXTROAMPHETAMINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; MORPHINE; NARCOTICS; PHENCYCLIDINE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL;

EID: 1842556155     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.028878     Document Type: Article

References (14)

1. College of American Pathologists. 2003 CAP survey UDS-A. Northfield, IL, College of American Pathologists, 2003:4-7.
2. Department of Health and Human Services. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies. Fed Regist 2003;68:52214-5.
3. Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing programs. Fed Regist 1988;53: 11970-89.
4. Department of Health and Human Services. Revised mandatory guidelines for federal workplace drug testing programs. Fed Regist 1994;59:29908-31.
5. Huestis MA, Mitchell JM, Cone EJ. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clin Chem 1994;40:729-33.
6. Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing programs. Fed Regist 1997;62: 51118-20.
7. Wingert WE. Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results. Clin Chem 1997;43:100-3.
8. Soldin SJ, Morales AJ, D'Angelo U, Bogema SC, Hicks JC. The importance of lowering the cut-off concentrations for urine screening and confirmatory tests for benzoylecgonine/cocaine [Abstract]. Clin Chem 1991;37:993.
9. Hill J. Evaluation of renal function in pediatrics. In: Hicks JM, Boeckx R, eds. Pediatric clinical chemistry. Philadelphia: WB Saunders Co., 1984:107-19.
10. Hattab EM, Goldberger BA, Johannsen LM, Kindland PW, Ticino F, Chronister CW, et al. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures. Ann Clin Lab Sci 2000;30:85-91.
11. Dudley RA, Edwards P, Ekins RP, Finney DJ, McKenzie IG, Raab GM, et al. Guidelines for immunoassay data processing. Clin Chem 1985;31:1264-71.
12. Dietzen DJ, Koenig J, Turk J. Facilitation of thin-layer chromatographic identification of opiates by derivatization with acetic anhydride or methoxyamine. J Anal Toxicol 1995;19:299-303.
13. Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol 1995;19:443-9.
14. Dietzen DJ, Ecos K, Friedman D, Beason S. Positive predictive values of abused drug immunoassays on the Beckman Synchron in a veteran population. J Anal Toxicol 2001;25:174-8.